Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2017-08-14 2017-10-24 19213
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-06-06 2022-07-22 162091
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-12-12 2020-01-22 101088
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75608
APO-AMLODIPINE-ATORVASTATIN 40MG 5MG TABLET Resolved 2022-06-06 2022-07-22 162088
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2021-05-07 2021-05-26 138951
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2023-12-08 2024-01-19 212940
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2019-12-12 2020-01-15 101082
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-03-18 2022-04-01 156983
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2020-07-08 2020-07-13 119683
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2023-07-07 2023-09-01 197872
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2017-06-08 2017-08-08 12278
APO-AMLODIPINE-ATORVASTATIN 40MG 10MG TABLET Resolved 2022-12-02 2023-03-02 176924
APO-AMLODIPINE-ATORVASTATIN 5MG 10MG TABLET Resolved 2018-02-01 2018-07-03 37945
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2021-05-07 2021-05-26 138954
APO-AMLODIPINE-ATORVASTATIN 5MG 40MG TABLET Resolved 2021-04-23 2021-05-26 137956
APO-AMLODIPINE-ATORVASTATIN 20MG 10MG TABLET Resolved 2021-10-01 2021-11-15 146500
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2021-08-27 2021-11-19 144656
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2023-02-16 2023-03-02 185025
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2018-01-31 2018-07-03 37717
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557